Infection assessment of totally implanted long-term venous access devices

Journal of Vascular Access

Volumn 7, Issue 1, 2006, Pages 24-28

  Brouns, Francis ^a   Schuermans, A ^a   Verhaegen, J ^a   De Wever, I ^a   Stas, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Catheter related infections; Infection assessment; Port content culture

Indexed keywords

SILICON;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CATHETER INFECTION; CATHETER REMOVAL; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CULTURE TECHNIQUE; DEVICE INFECTION; DIAGNOSTIC TEST; FEMALE; HUMAN; IMPLANTATION; ISOLATION PROCEDURE; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; NONHUMAN; PROSPECTIVE STUDY; PUNCTURE; RELIABILITY; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; VASCULAR ACCESS DEVICE;

EID: 33646394054     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980600700105     Document Type: Article

References (20)

1. Kock HJ, Peitsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: Experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998; 22: 12-6.
2. Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 2002; 3: 684-93.
3. Puig La Calle J Jr, Lopez Sanchez S, Piedrafita Serra E, Allende Honorato L, Artigas Raventos L, Puig La Calle J. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 1996; 62: 273-8.
4. Viot M. Intravenous access: related problems in oncology. Int J Antimicrob Agents 2000; 16: 165-8.
5. Chang L, Tsai J, Huang S, Shih C. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003; 31: 34-9.
6. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992; 10: 1943-8.
7. Barnes J, Lucas N. When should the "infected" subcutaneous infusion reservoir be removed? Am Surg 1996; 62: 203-7.
8. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular-related bacteriaemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemoth 2005; 55: 90-4.
9. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8: 265-74.
10. Peetermans W, Van Wijngaerden E. Katheterinfecties. In: De Wever I, Stas M, Mulier S. eds. Poorten en katheters voor langdurige IV therapie. Leuven University Press 1998; 197-206.
11. Ray CE. Infectious complications of venous access devices. Tech Vasc Interv Radiol 2002; 5: 78-84.
12. Capdevila JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis 1998; 2: 230-6.
13. Douard MC, Arlet G, Longuet P, et al. Diagnosis of venous access port-related infections. Clin Infect Dis 1999; 29: 1197-202.
14. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis 2001; 32: 1776-83.
15. Stas M, Mulier S, Pattyn P, Vijgen J, De Wever I. Peroperative intravasal electrographic control of catheter tip position in access ports placed by venous cut-down technique. Eur J Surg Oncol 2001; 27: 316-20.
16. Di Carlo I, Cordio S, La Greca G, et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 2001; 136: 1050-3.
17. O'Grady MP, Maki DG, Alexander M, et al. CDC Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51(RR-10): 1-29.
18. Mermel L, Farr B, Sheretz R, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-72.
19. Dosa E, Doczi I, Wilhelms D, Kekulé AS, Nagy E. Detection of biofilm production of candida isolates. 2nd Trends in Medical Mycology, 23-23 Oct. 2005.
20. Barbut F, Soukouna S, Lalande V, et al. Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation. Pathol Biol 2004; 52: 566-74.